ArticleCell reports methods2026
ATACompass enables cross-species cell identity mapping for scATAC-seq without gene annotations.
Article in Cell reports methods, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Single-cell assay for transposase-accessible chromatin with sequencing (scATAC-seq) provides insights into transcriptional regulation, but there remain challenges in cell identity annotation due to data sparsity and limited gene regulatory annotations, particularly in non-model organisms. To address these limitations, we present ATACompass, a sequence-based framework for cell annotation that directly encodes chromatin accessibility peak sequences using the DNA foundation model HyenaDNA and large language models. By incorporating controlled sequence mutations for data augmentation, ATACompass achieves performance competitive with or superior to existing state-of-the-art methods in intra-species tasks. Critically, ATACompass enables zero-shot cross-species cell annotation by restricting input data to conserved sequences shared between species, allowing non-model organism data to be annotated without species-specific prior knowledge. Furthermore, the integration of datasets from representative evolutionary lineages enhances predictive accuracy, enabling comprehensive annotation across species. In summary, ATACompass provides a gene annotation-independent framework for studying cell types and regulatory landscapes, especially in non-model organisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.